Canadian Rheumatology Association updates its living guidelines with the addition of three new recommendations for glucocorticoid use in rheumatoid arthritis.
Canadian Rheumatology Association’s “living” treatment recommendations provide contemporary guidance on the management of patients with axial spondyloarthritis.
